Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KB001 in Cystic Fibrosis with Pseudomonas Aeruginosa
NCT00638365Phase 2Completed
- Sponsor
- Humanigen
- Start
- Mar 2008
- Primary completion
- Mar 2009
- Modality
- Antibody Fragments
- Countries
- 1
01
Overview
A Phase 2 trial of KB-001 in cystic fibrosis (CF), sponsored by Humanigen. Started Mar 2008; status: completed.
02
Drugs
KB-001
03
Conditions
cystic fibrosis (CF)
Beyond the preview
Go deeper on NCT00638365.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00638365.